Coumarin Derivatives as Anticancer Agents for Lung Cancer Therapy: A Review
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
18
Page:
964-984
Author(s):
Manvendra Kumar, Ramit Singla, Jyoti Dandriyal and Vikas Jaitak*
A Review on Melatonin’s Effects in Cancer: Potential Mechanisms
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
18
Page:
985-992
Author(s):
Aysegul Hanikoglu, Ertan Kucuksayan, Rana Cagla Akduman and Tomris Ozben*
Synthesis and Evaluation of Heterocycles Based Chalcone Derivatives as Antiproliferative Agents
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
18
Page:
1044-1053
Author(s):
Betül Kaya Çavuşoğlu, Özlem Atlı, Gözde Görmüş, Yusuf Özkay* and Zafer Asım Kaplancıklı
Emodin Enhances the Chemosensitivity of Endometrial Cancer by Inhibiting ROS-Mediated Cisplatin-resistance
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
18
Page:
1054-1063
Author(s):
Ning Ding, Hong Zhang, Shan Su, Yumei Ding, Xiaohui Yu, Yujie Tang, Qingfang Wang and Peishu Liu*
Synthesis and Anticancer Activity of Some 1H-inden-1-one Substituted (Heteroaryl)Acetamide Derivatives
Journal:
Letters in Drug Design & Discovery
Volume:
16
Page:
111-118
Author(s):
Ahmet Cagri Karaburun, Nalan Gundogdu-Karaburun*, Leyla Yurttas, Ismail Kayagil and Seref Demirayak
The Value of Biomarkers in Optimizing the Use of Immuno-oncologic Therapy
Journal:
Current Drug Targets
Volume:
20
Page:
81-86
Author(s):
Carlos G. Ferreira, Andrea Nicolini*, Liliana Dalurzo, Stephen Stefani, Vanessa Teich and Natasha Leighl
Breaking the Barrier of Cancer Through Liposome Loaded with Phytochemicals
Journal:
Current Drug Delivery
Volume:
16
Page:
3-17
Author(s):
Tapan Kumar Giri*
Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression
Journal:
MicroRNA
Volume:
8
Page:
68-75
Author(s):
Jeyalakshmi Kandhavelu, Kumar Subramanian, Amber Khan, Aadilah Omar, Paul Ruff and Clement Penny*
Clinical and Serological Biomarkers of Treatment’s Response in Multiple Sclerosis Patients Treated Continuously with Interferonβ-1b for More than a Decade
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
17
Page:
780-792
Author(s):
Laura Iulia Bărcuţean, Andreea Romaniuc*, Smaranda Maier, Zoltan Bajko, Anca Moţăţăianu, Huţanu Adina, Iunius Simu, Sebastian Andone and Rodica Bălaşa
Alam K et al. (2018) Drug Metabolism Letters; 12, 24-32.
Journal:
Drug Metabolism Letters
Volume:
12
Page:
153-153
Author(s):
Tristan M. Sissung, Cindy Chau, Douglas K. Price and William D. Figg*